Figure 4.
Event-free survival (EFS) (a) and overall survival (b) of primarily relapsed patients with PTCL who underwent stem cell transplantation. ALK-positive ALCL had a statistically significant better EFS than other PTCL.
(Update from ref. 44, courtesy of Madan Jagasia, MBBS)